No insider purchase over the last 90 days. The latest, by 拉萨爱力克投资咨询有限公司, was filed 05 Jul 2022.
Sinocelltech Group Limited: what insiders have been doing
Sinocelltech Group Limited belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Nothing new has been filed by managers of Sinocelltech Group Limited in twelve months, the latest record being from 5 July 2022.
Our records for Sinocelltech Group Limited go back to 2022, with 7 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +5.8%Entry CN¥56.69 · Close at T+365 CN¥59.99
- +10.3%Entry CN¥54.40 · Close at T+365 CN¥60.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 180,000 shares100.0% of flowA股XSHGSSE:173000005652000060Canonical exit: 3 Oct 2022 (T+90)
- 63,000 shares21.0% of flowA股XSHGSSE:173000005648954050Canonical exit: 2 Oct 2022 (T+90)
- 50,000 shares16.1% of flowA股XSHGSSE:173000005640886900Canonical exit: 29 Sept 2022 (T+90)
- 70,000 shares22.7% of flowA股XSHGSSE:173000005636176260Canonical exit: 28 Sept 2022 (T+90)
- 60,000 shares19.4% of flowA股XSHGSSE:173000005621912450Canonical exit: 26 Sept 2022 (T+90)
- 55,000 shares18.2% of flowA股XSHGSSE:173000005618588500Canonical exit: 25 Sept 2022 (T+90)
- 8,000 shares2.7% of flowA股XSHGSSE:173000005614885540Canonical exit: 22 Sept 2022 (T+90)
7 of 7 declarations
About Sinocelltech Group Limited
神州细胞 is a company focused on the health and pharmaceutical sector, specializing in the development of cell therapies. It is listed on the XSHG market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
